Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Tempus
5697
Tempus
Technology
Information Technology
Artificial Intelligence
Health Care
Medical
Medical Devices
Tempus is a technology company that has built an operating system to battle cancer.
Suggest edits
Type
B2b
Founded
2015
Raised
$680M
Follow us
Featured on
Also headquartered in Chicago
Motorola
Boeing
Dyson
Signal
United Airlines
Walgreens
Lightspeed
Internet Retailer
AbbVie
Thoma Bravo
Companies in the same industry
Sana
Cardiomo
KwitCase™
Procura
Doctolib
Aidence
Coala Life
Twitter
Somnox
HealthMode
Alexa global traffic share
Twitter followers
Overview
Funding
5
Add info
Latest funding
Show all
$200,000,000
Venture capital (Series G) - 2020
Google
T. Rowe Price
Baillie Gifford
+2
$100,000,000
Venture capital (Series G) - 2020
T. Rowe Price
Baillie Gifford
NEA
+2
Team Size
1–10
Employees
I work here
Location
Chicago
,
United States
Headquarters
Explore Chicago
SiliconBeat
Pac-12 partners with Tempus Ex Machina on data deal, paving the way for a vital new revenue stream
$200,000,000
Venture capital (Series G)
neurons.AI
Precision medicine company Tempus lands $200M to expand into infectious diseases, mental health
neurons.AI
Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance …
neurons.AI
Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance …
neurons.AI
Tempus Announces Strategic Collaboration With Janssen Applying Data Science to Enhance …
CNBC Tech
Tempus: Health start-up backed by Groupon co-founder joins the fight against Covid-19
$100,000,000
Venture capital (Series G)
Pulse 2.0
Tempus: $100 Million Funding And $5 Billion Valuation
$200,000,000
Venture capital
TechCrunch
,
TechCrunch
Groupon cofounder Eric Lefkofsky just raised another $200 million for his newest company, Tempus
$110,000,000
Venture capital (Series E)
FinSMEs
,
PE HUB
Tempus Raises $110M in Series E Financing
Funding
Cloud
Health
$70,000,000
Venture capital (Series C)
PE HUB
,
TechCrunch
NEA and Revolution Growth leads Series C round for Tempus